circulating miRNA European Consortium Seeks to Develop Liquid Biopsy Test for Prostate, Testicular Cancer Premium The European Commission awarded a consortium of private companies and academic researchers €759,000 recently to carry out their plans. DiamiR Wins $3.9M in NIH Funding for Neurological Disease Diagnostic Development The two grants awarded will support DiamiR's development of microRNA diagnostics for mild cognitive impairment, Alzheimer's disease, and Rett syndrome. MiR Scientific Validates Urine-Based Cancer Tests, Awaits NY State Approval Premium The firm recently published a study describing three assays for prostate cancer and reporting their sensitivity and specificity in case-control cohort. Blood-Based MicroRNA Signatures Can Distinguish Individuals With Lung Cancer A retrospective cohort study uncovered microRNA signatures that could tell lung cancer patients apart from others, including patients with other, non-tumor lung conditions. MiR Scientific Prepares to Launch Tests for Prostate, Bladder Cancer Premium The company is seeking NY State approval for its lab, which would allow it to offer both tests as LDTs, hopefully by the end of this year or early next. Dec 6, 2018 Cancer Early Detection Firm Ark Launches With $40M Series A Investment Sep 19, 2018 New Technique Allows Sequencing of Short RNAs From Dried Blood Spots, Other Small Samples Premium Jul 20, 2018 MiR Scientific Prepares Launch of First Clinical Cancer Test, Buoyed by New Data Premium Apr 10, 2018 Quadrant Biosciences Licenses SUNY, Penn State Epigenetic Biomarkers for Neuro Diseases Nov 14, 2017 Dana-Farber Team Developing MicroRNA Liquid Biopsy to Diagnose Ovarian Cancer Premium Mar 10, 2017 Chinese Startup HeliTec Launches Large Liquid Biopsy Study Nov 11, 2016 Circulating Maternal MicroRNAs Distinguish Infants Affected by Fetal Alcohol Syndrome Sep 6, 2016 Prostate Cancer Grades Can Be Distinguished Using MicroRNA Signature, Study Finds Mar 9, 2016 Startup Miroculus Shares Vision for Rapid, Inexpensive miRNA Diagnostics at Tri-Con Premium Dec 31, 2015 Early Data Encouraging for Development of Blood-Based MicroRNA Test for Germ Cell Cancers Premium Nov 6, 2015 HTG Updates NGS Assay Pipeline; Academic Partners Working on microRNA-Based Ovarian Cancer Subtyping Aug 28, 2015 Moffitt Team Uses Nanostring Tech to ID MiRNA Signature for Early Pancreatic Cancer Detection Premium Jul 17, 2015 With NCI Funding, Baylor Team Developing microRNA-Based Colorectal Cancer Screen Premium May 6, 2015 With NCI Grant, Librede Looks to Develop Nanopore-Based microRNA Diagnostic Premium Feb 27, 2014 Singapore's MiRxes Spins Out from A*Star with Novel qPCR Assay Platform for microRNA Analysis Premium Feb 27, 2014 Q&A: UMich's Muneesh Tewari on miRNAs as Cancer Biomarkers, ddPCR as Detection Method Premium May 10, 2012 Australian Team Finds Blood miRNA with Potential for Early Diagnosis of Malignant Mesothelioma Premium Breaking News In Brief This Week: Veracyte, Danaher, Chembio Diagnostics, and More Decode Genetics Plasma Proteome Study Improves Understanding of Disease Pathogenesis Euformatics Gains CE-IVD Mark for OmnomicsNGS People in the News: New Appointments at SomaLogic, 23andMe, Pacific Biosciences, More New Products Posted to GenomeWeb: GenDx, Eurofins Technologies, Codex DNA, More Variant Identified in Amish Population Appears to Protect From Cardiovascular Disease The Scan Steps for Quick Review The US Food and Drug Administration is preparing for the quick review of drugs and vaccines for the Omicron variant, according to the Wall Street Journal. Moving Away From Using Term 'Race' A new analysis finds that geneticists are using the term "race" in their papers less than in years past, as Science reports. Point of the Program The Guardian writes that some scientists have called the design of a UK newborn sequencing program into question. Science Papers Present Multi-Omic Analysis of Lung Cells, Regulation of Cardiomyocyte Proliferation In Science this week: a multi-omic analysis of lung cells focuses on RIT1-regulated pathways, and more.